Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human cell-based artificial antigen-presenting cells for cancer immunotherapy.

Immunological reviews - 1 Jan 2014

Butler Marcus O, Hirano Naoto

Abstract excerpt

Adoptive T-cell therapy, where anti-tumor T cells are first prepared in vitro, is attractive since it facilitates the delivery of essential signals to selected subsets of anti-tumor T cells without unfavorable immunoregulatory issues that exist in tumor-bearing hosts. Recent clinical trials have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen-Presenting Cells
Share to Combined Modality Therapy
Share to Genetic Engineering

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Memory

Share to Immunotherapy, Adoptive

Share to K562 Cells

Share to Receptors, Antigen, T-Cell

Share to T-Lymphocyte Subsets

Source

Open in PubMed Open full text

Identifiers

PMID: 24329798
DOI: 10.1111/imr.12129
PMCID: PMC3869003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24329798-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human cell-based artificial antigen-presenting cells for cancer immunotherapy.PMID 24329798Read ↗

Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.Semantic proximity Read ↗

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cellsSemantic proximity Read ↗

The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.Semantic proximity Read ↗

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes.Semantic proximity Read ↗

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.Semantic proximity Read ↗

A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.Semantic proximity Read ↗

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cellsSemantic proximity Read ↗

Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated MicrospheresSemantic proximity Read ↗

Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantationSemantic proximity Read ↗

Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cell therapiesSemantic proximity Read ↗

Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells.Semantic proximity Read ↗

Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory MoleculesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.